ENLV: Enlivex Therapeutics Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23.97
Enterprise Value ($M) 21.20
Book Value ($M) 26.59
Book Value / Share 1.21
Price / Book 0.90
NCAV ($M) 23.90
NCAV / Share 1.09
Price / NCAV 1.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.69
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.63

Liquidity (mrq)
Quick Ratio 9.71
Current Ratio 9.71

Balance Sheet (mrq) ($M)
Current Assets 27.11
Assets 29.80
Liabilities 3.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 9.75 1.48

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 70,102 235,828 29.73
2025-03-13 19,046 115,440 16.50
2025-03-12 15,017 77,723 19.32
2025-03-11 40,663 116,585 34.88
2025-03-10 85,303 372,705 22.89

(click for more detail)

Similar Companies
ELDN – Eledon Pharmaceuticals, Inc. ELTX – Elicio Therapeutics, Inc.
ELUT – Elutia Inc. ENSC – Ensysce Biosciences, Inc.
ENTO – Entero Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io